Revalesio
PrivateLast Round
VC Round
Jun 9, 2022
Total Funding Raised
$14.5M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Revalesio is a biotechnology company that develops anti-inflammatory therapeutic drugs designed to treat a variety of neurological diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Revalesio Comparables
Compare Revalesio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ZZ Biotech | 84% | |
| Astrocyte Pharmaceuticals Inc. | 82% | |
| Pharmazz, Inc. | 79% |
Revalesio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 9, 2022 | ||||
| VC Round | Jul 22, 2020 | ||||
| VC Round | Jun 27, 2018 | ||||
| Grant | Sep 20, 2017 | ||||
| VC Round | Jul 5, 2016 | ||||
Series B | Apr 23, 2014 |
Revalesio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The ALS Association | Grant |
| Northeast ALS Consortium | Grant |
| ALS Finding a Cure | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 68% MoM.
- Jul 20, 2026
Open roles increased from 0 to 12, representing 57% of headcount.
Revalesio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Revalesio's valuation, stock price, and market status.
Is Revalesio a public or private company?
Revalesio is a private company.
What is the current stock price of Revalesio?
Revalesio is a private company with no public stock price. No recent secondary market data is available.
How much is Revalesio worth (valuation)?
Valuation information for Revalesio is not publicly available.
Can I buy Revalesio stock?
Revalesio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Revalesio's last funding round?
Revalesio's most recent funding round was VC Round on June 9, 2022.
Who are the main investors in Revalesio?
Key investors in Revalesio include The ALS Association, Northeast ALS Consortium, ALS Finding a Cure.
Will Revalesio IPO soon?
No public IPO plans have been announced for Revalesio.
How can I track Revalesio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Revalesio's secondary market activity and sign up for updates.